Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60307-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- FOLR1 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated FOLR1 antibody (Cat. #60307-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2B4B7
- Vial size
- 20ul, 150ul
Submitted references Dual-receptor PET imaging of ovarian cancer using a (68)Ga-labeled heterodimer targeting folate receptor and HER2.
Evaluation of Laboratory-Derived Immunohistochemical Assays for Folate Receptor α Expression in Epithelial Ovarian Cancer and Comparison With a Companion Diagnostic.
Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells.
Colocalization of Cancer-Associated Biomarkers on Single Extracellular Vesicles for Early Detection of Cancer.
Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian Cancer.
High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Novel Anti-FOLR1 Antibody-Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells.
Shi X, Wu Z, Yuan Y, Wang Y, Yang S, Li R
American journal of nuclear medicine and molecular imaging 2025;15(4):130-139
American journal of nuclear medicine and molecular imaging 2025;15(4):130-139
Evaluation of Laboratory-Derived Immunohistochemical Assays for Folate Receptor α Expression in Epithelial Ovarian Cancer and Comparison With a Companion Diagnostic.
Deutschman E, Fulton R, Sloss CM
Archives of pathology & laboratory medicine 2025 Oct 1;149(10):930-937
Archives of pathology & laboratory medicine 2025 Oct 1;149(10):930-937
Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells.
Kucerova L, Fekiacova A, Udvorkova N, Malcharkova P, Blahova V, Jochova S, Kalavska K, Cierna Z, Mego M
Cells 2025 Feb 15;14(4)
Cells 2025 Feb 15;14(4)
Colocalization of Cancer-Associated Biomarkers on Single Extracellular Vesicles for Early Detection of Cancer.
Salem DP, Bortolin LT, Gusenleitner D, Grosha J, Zabroski IO, Biette KM, Banerjee S, Sedlak CR, Byrne DM, Hamzeh BF, King MS, Cuoco LT, Santos-Heiman T, Barcaskey GN, Yang KS, Duff PA, Winn-Deen ES, Guettouche T, Mattoon DR, Huang EK, Schekman RW, Couvillon AD, Sedlak JC
The Journal of molecular diagnostics : JMD 2024 Dec;26(12):1109-1128
The Journal of molecular diagnostics : JMD 2024 Dec;26(12):1109-1128
Folic Acid-Modified Fluorescent-Magnetic Nanoparticles for Efficient Isolation and Identification of Circulating Tumor Cells in Ovarian Cancer.
Pan Y, Wang Z, Ma J, Zhou T, Wu Z, Ding P, Sun N, Liu L, Pei R, Zhu W
Biosensors 2022 Mar 21;12(3)
Biosensors 2022 Mar 21;12(3)
High-Performance Self-Cascade Pyrite Nanozymes for Apoptosis-Ferroptosis Synergistic Tumor Therapy.
Meng X, Li D, Chen L, He H, Wang Q, Hong C, He J, Gao X, Yang Y, Jiang B, Nie G, Yan X, Gao L, Fan K
ACS nano 2021 Mar 23;15(3):5735-5751
ACS nano 2021 Mar 23;15(3):5735-5751
Novel Anti-FOLR1 Antibody-Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells.
Matsunaga Y, Yamaoka T, Ohba M, Miura S, Masuda H, Sangai T, Takimoto M, Nakamura S, Tsurutani J
Antibodies (Basel, Switzerland) 2021 Feb 1;10(1)
Antibodies (Basel, Switzerland) 2021 Feb 1;10(1)
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The FOLR1 antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human FOLR1. This antibody recognizes human antigen. The FOLR1 antibody has been validated for the following applications: ELISA, WB analysis.